Effects of Positive Airway Pressure Therapy on Older Veterans with COPD and Sleep Apnea
Official title: Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
Run by VA Office of Research and Development · NCT04179981 · Data updated 2026-11-12
This study is testing if positive airway pressure therapy can help older veterans with both COPD and sleep apnea sleep better, feel less tired during the day, and think more clearly compared to standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 668 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Detroit, Michigan) |
| Status | Recruiting |
| Started | December 1, 2020 |
| Main results expected | September 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | June 5, 2026 |
| Trial ID | NCT04179981 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are older veterans aged 60 and above with moderate-to-severe obstructive sleep apnea and chronic obstructive pulmonary disease.
✕Probably not a fit
Patients with central sleep apnea, significant cognitive impairments, or those currently receiving PAP treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of positive airway pressure (PAP) therapy on clinical outcomes in older veterans suffering from Overlap Syndrome, which combines chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA). The research aims to determine whether PAP therapy can improve sleep quality, reduce daytime sleepiness, and enhance cognitive function compared to conservative care. The study will also compare the effectiveness of continuous positive airway pressure (CPAP) and noninvasive positive airway pressure ventilation (NIPPV) in achieving these outcomes. By focusing on this specific veteran population, the study seeks to address a significant gap in existing research regarding the management of OSA and COPD together.
Why it matters
Potential benefit: If successful, this study could significantly improve the quality of life and cognitive function for older veterans with Overlap Syndrome.
How similar studies have gone: While there is limited research specifically on PAP therapy for Overlap Syndrome, studies on PAP therapy for sleep apnea and COPD separately have shown positive outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * OSA with moderate-to-severe disease, AHI 20 per hour by in-lab polysomnography with concomitant moderate-severe COPD based on pulmonary function tests (PFTS) and with past significant history (\>10 pack-years) of smoking * Male or female gender * Age greater than or equal to 60 years * Stable treatment regimen for COPD Exclusion Criteria: * Current or prior treatment with PAP or oral appliance * Central sleep apnea defined as central apnea index \>5 per hour and comprising 50% of AHI * Known primary neuromuscular diseases * Disorders that may impact cognitive function including: * neurodegenerative disorders * traumatic brain injury * untreated PTSD and/or history of learning disability * Medicines that may cause or alter sleepiness: sedative hypnotics, or stimulants as these may alter the results * Patient is actively suicidal due to depression, unstable mental health condition * Epworth sleepiness score \>16 (severe sleepiness) or a near-miss or prior automobile accident due to sleepiness within the past 12 months * Narcolepsy is the primary sleep disorder, with requirement of stimulant medications * Employed as a commercial driver or operating heavy machinery * On long-term oxygen therapy prior to start of study, more than 12 hr/day * Patients is unable to use either a nasal or face mask (e.g., facial trauma, claustrophobia) * Consumption of \>3 alcoholic beverages per day or current use of some illicit drugs, as these may contribute to cognitive deficits * Patients who cannot give informed consent * Patients receiving hospice care * Pregnant women due to unknown risks
Where it's running
-
John D. Dingell VA Medical Center, Detroit, MI
Detroit, Michigan, United States Recruiting
Study contacts
- Principal investigator: Susmita Chowdhuri, MD MS — John D. Dingell VA Medical Center, Detroit, MI
- Study coordinator: Ruchi Rastogi, MS
- Email: ruchi.rastogi@va.gov
- Phone: (313) 576-4464
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcranial red/near-infrared light therapy for lingering sleepiness in obstructive sleep apnea
This trial will test whether gentle red/near-infrared light to the head (tPBM) can reduce ongoing daytime sleepiness in people with moderate-to-severe obstructive sleep apnea who use CPAP.
-
Investigating the effects of sleep apnea and COPD on heart health
This study is testing how having both sleep apnea and COPD affects heart health and whether a specific breathing treatment works better than oxygen therapy for improving heart outcomes in these patients.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.